Halozyme Therapeutics, Inc.
NSQ · HALO
Fundamentals
Market cap
$9.72B
Price / Earnings ratio
27.9x
Price / Sales ratio
6.4x
Price / Book ratio
44.3x
Return on assets
0.1%
Ex-Dividend date
N/A
Last payment date
N/A
Dividend amount
$0.00
Dividend yield
0.0%
Debt / Equity ratio
N/A


